Smokers with multiple sclerosis are more likely to report comorbid autoimmune diseases

Academic Article

Abstract

  • Background/Aims: Smoking is a risk factor for multiple sclerosis (MS) and autoimmune disease, and might explain an increased risk of comorbid autoimmune disease (CAD) in MS. We compared the risk of CAD in smokers and nonsmokers with MS. Methods: Participants enrolled in the North American Research Committee on Multiple Sclerosis Registry reported their smoking status, the presence of CAD and the year of diagnosis. We used multivariable logistic regression to determine the independent association between smoking and CAD. We also compared the risk of developing a CAD in current smokers versus never-smokers who did not report any CAD at MS onset, using a proportional hazards model. Results: Among 8,875 participants reporting comorbidities and smoking status, 1,649 (18.5%) reported a CAD. In a multivariable logistic model, ever-smokers had increased odds of reporting a CAD (odds ratio: 1.22; 95% CI: 1.08-1.38). Among the 7,830 participants without a CAD at onset of MS who reported their smoking status, including the age at which they started smoking, 3,035 (36.8%) currently smoked, while 3,805 (48.6%) never smoked. After adjustment, smokers had an increased risk of developing any autoimmune disease (hazard ratio: 1.23; 95% CI: 1.08-1.41) after MS onset. Conclusion: Smoking is associated with an increased risk of CAD in MS. Copyright © 2011 S. Karger AG, Basel.
  • Authors

    Published In

  • Neuroepidemiology  Journal
  • Digital Object Identifier (doi)

    Author List

  • Marrie RA; Horwitz RI; Cutter G; Tyry T; Vollmer T
  • Start Page

  • 85
  • End Page

  • 90
  • Volume

  • 36
  • Issue

  • 2